Torrent Pharmaceuticals Acquires Additional Stake in JB Chemicals
Filing Summary
Torrent Pharmaceuticals Ltd has acquired 37,82,566 equity shares of J.B. Chemicals & Pharmaceuticals Ltd, representing 2.36% of its equity share capital. This acquisition was completed on January 23, 2026, under a share purchase agreement dated July 3, 2025. Following this transaction, Torrent Pharmaceuticals now holds a total of 7,82,65,402 equity shares in JB Chemicals, amounting to 48.75% of its equity share capital. This update was communicated in compliance with SEBI regulations.
Torrent Pharmaceuticals Ltd has announced the acquisition of 37,82,566 equity shares of J.B. Chemicals & Pharmaceuticals Ltd. This acquisition represents 2.36% of the equity share capital of JB Chemicals on a fully diluted basis. The transaction was executed on January 23, 2026, as per the share purchase agreement dated July 3, 2025, between Torrent Pharmaceuticals and certain employees of JB Chemicals.
Following this acquisition, Torrent Pharmaceuticals now holds a total of 7,82,65,402 equity shares in JB Chemicals. This represents 48.75% of the equity share capital of JB Chemicals on a fully diluted basis. The company has communicated this update in accordance with Regulation 30 and Regulation 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Torrent Pharmaceuticals is focused on expanding its presence in the pharmaceutical sector through strategic acquisitions and partnerships. The company prioritizes growth in its core therapeutic areas and aims to enhance its product portfolio through targeted investments.